Edwards (EW) CVP Wayne Markowitz Exercises Options, Sells 9,628

What Happened

• Wayne Markowitz, CVP, JAPAC at Edwards Lifesciences, exercised 9,628 stock options and sold the resulting 9,628 shares in an open-market transaction on July 28, 2026.
• Exercise price: $74.02 per share (total exercise cost ≈ $712,665). Sale price: $85.06 per share (gross proceeds ≈ $818,958). Net proceeds roughly $106,300.
• The Form 4 shows the exercise (derivative conversion) and an immediate sale — a cashless exercise followed by an open-market sale (routine monetization, not necessarily a signal of company prospects).

Key Details

• Transaction date: 2026-07-28 (filed same day).
• Exercise: 9,628 shares at $74.02 (Acquired) — $712,665.
• Sale: 9,628 shares at $85.06 (Disposed) — $818,958.
• A derivative disposition line at $0 is also reported (reflects the option conversion/derivative reporting mechanics).
• Shares owned after the transaction: not specified in this Form 4 (the filing only reports changes).
• No 10b5‑1 plan, tax‑withholding, or late-filing flags are disclosed.

Context

• For retail investors: this was an exercise of options followed by an immediate sale (cashless exercise), converting option value to cash. Such transactions are common for insiders realizing gains on vested equity; they are routine and factual disclosures rather than direct endorsements or criticisms of company outlook.